19 January 2024
Acknowledgment of the Reviewers of Scientia Pharmaceutica in 2023
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
In recognizing the exceptional efforts of our reviewers in 2023, we express our sincere gratitude for upholding the high standards of Scientia Pharmaceutica. Their commitment ensured the rigorous peer review that is integral to quality academic publishing.
In 2023, Scientia Pharmaceutica received 223 review reports, from 203 reviewers. This past year, we worked with reviewers from 45 countries and regions, reflecting the diversity in our collaboration with research communities. Their dedication shapes scholarly discourse and advances global research. The editorial team expresses gratitude for the vital role played by each reviewer in the Scientia Pharmaceutica family throughout 2023, and we look forward to their continued support in 2024.
The following are the reviewers who have consented to show their names:
Abdul Aleem Mohammed | Kiran Lokhande |
Aiman Abu Ammar | kumarappan Chidambaram |
Akshaya Bhagavathula | Liliya Logoyda |
Alarico Ariani | Luis Alfonso Trujillo-Cayado |
Amine Elbouzidi | Małgorzata Matysek |
Ana Hortência Fonseca Castro | Maosud Soroush Bathaei |
Ana Luísa De Sousa-Coelho | Marek Wesolowski |
Andrej Belančić | Maria Pia Ferraz |
Angel Josabad Alonso-Castro | Marlena Godlewska |
Anna Drabczyk | Michal Ordak |
Anna Hering | Mircea Darabantu |
Anna Timofeeva | Mirolyuba Ilieva |
Annarita Nappi | Noritaka Nakamichi |
Ao Shi | Paloma de la Torre-Iglesias |
Armanda Santos | Patrícia Pires |
Ayhan Celik | Paulo Santos |
Bence Sipos | Peter Timmins |
Bojana Vasiljevic | Pinaki Bhattacharjee |
Brateen Shome | Rais Ansari |
Carlos Gamarra-Luques | Rajendran Kamalabai Selvakesavan |
Chennaiah Ande | Roberta Rocca |
Chung-Hsin Wu | Roxana Liana Lucaciu |
Cosmin Victor Ene | Sabrina Taliani |
Daniel Becker | Sally Freeman |
Drago Beslo | Sarah Jiang |
Elena Tarca | Serhii Holota |
Eleni Mavrogonatou | Sherif T. S. Hassan |
Emanuel Hernández Núñez | Shyam Kumar Gudey |
Federico Herrera | Silvano Dragonieri |
Ferdinando Fiorino | Sushobhan Mukhopadhyay |
Frank Schnütgen | Swarnali Roy |
Gina Mendez-Callejas | Takehisa Hanawa |
Haijun Liu | Thomas Endres |
Halilibrahim Ciftci | Toyofumi Suzuki |
Ieva Janulaityte | Tulasigeri Totiger |
István Antal | Vidya Niranjan |
Jakub Staniczek | Vijay Radhakrishnan |
Jaswanth B.H. Gowda | Xin Li |
Javad Mottaghipisheh | Ygor Jessé Ramos |
Jean Boutin | Yogesh Sutar |
Joanna Sobiak | Yung-Hsiang Chen |
Joy Mitra | Zheng-Yuan Su |
Jun Liu |